Mutations of polycomb-associated geneASXL1in myelodysplastic syndromes and chronic myelomonocytic leukaemia-Reference-Cited by-同舟云学术

Mutations of polycomb-associated geneASXL1in myelodysplastic syndromes and chronic myelomonocytic leukaemia

Published:2009-06 Issue:6 Volume:145 Page:788-800
ISSN:0007-1048
Container-title:British Journal of Haematology
language:en
Short-container-title:

Author:

Gelsi-Boyer Véronique,Trouplin Virginie,Adélaïde José,Bonansea Julien,Cervera Nathalie,Carbuccia Nadine,Lagarde Arnaud,Prebet Thomas,Nezri Meyer,Sainty Danielle,Olschwang Sylviane,Xerri Luc,Chaffanet Max,Mozziconacci Marie-Joëlle,Vey Norbert,Birnbaum Daniel

Publisher

Wiley

Subject

Hematology

Link

http://onlinelibrary.wiley.com/wol1/doi/10.1111/j.1365-2141.2009.07697.x/fullpdf

Reference54 articles.

1. UTX and JMJD3 are histone H3K27 demethylases involved in HOX gene regulation and development;Agger;Nature,2007

2. Variable breakpoints target PAX5 in patients with dicentric chromosomes: a model for the basis of unbalanced translocations in cancer;An;Proceedings of the National Academy of Sciences of the United States of America,2008

3. CXXC5 is a novel BMP4-regulated modulator of Wnt signaling in neural stem cells;Andersson;Journal of Biological Chemistry,2009

4. PHD fingers in human diseases: disorders arising from misinterpreting epigenetic marks;Baker;Mutation Research,2008

5. The myelodysplastic syndromes: diagnosis, molecular biology and risk assessment;Bennett;Hematology,2005

Cited by 508 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Targeting BIRC5 as a therapeutic approach to overcome ASXL1-associated decitabine resistance;Cancer Letters;2024-07

2. Generation and Characterization of Induced Pluripotent Stem Cells Carrying An ASXL1 Mutation;Stem Cell Reviews and Reports;2024-06-17

3. Additional Sex Combs-like Family Associated with Epigenetic Regulation;International Journal of Molecular Sciences;2024-05-08

4. Precision medicine targets for prostate cancers in African American men;2024-04-09

5. Targeting lysine demethylase 6B ameliorates ASXL1 truncation–mediated myeloid malignancies in preclinical models;Journal of Clinical Investigation;2024-01-02